Literature DB >> 1336699

Subcutaneous mastectomy with immediate reconstruction as treatment for early breast cancer.

B V Palmer1, K R Mannur, W B Ross.   

Abstract

Subcutaneous mastectomy and axillary dissection combined with immediate reconstruction was used to treat primary breast cancer in a consecutive series of 111 patients. Local recurrence occurred in 19 patients (17 per cent) during a mean follow-up of 30 (range 6-60) months. Complete control of local disease was achieved in all patients except one, who had terminal disease. Prophylactic radiotherapy was avoided for 83 per cent of patients, and good cosmetic results were obtained in 89 per cent. These results support the use of this technique in the treatment of early breast cancer.

Entities:  

Mesh:

Year:  1992        PMID: 1336699     DOI: 10.1002/bjs.1800791222

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  4 in total

1.  Capsular contracture of subcutaneous breast implant following hypofractionated stereotactic body radiotherapy for early stage lung cancer.

Authors:  Mary Frances McAleer; Peter Balter; M Kara Bucci; Shirly Kuruvila; Ritsuko Komaki; Joe Y Chang
Journal:  J Radiosurg SBRT       Date:  2013

Review 2.  Direct-to-Implant Subcutaneous Breast Reconstruction: A Systematic Review of Complications and Patient's Quality of Life.

Authors:  José Silva; Francisco Carvalho; Marisa Marques
Journal:  Aesthetic Plast Surg       Date:  2022-09-12       Impact factor: 2.708

3.  Comparison of Local Recurrence After Simple and Skin-Sparing Mastectomy Performed in Patients with Ductal Carcinoma In Situ.

Authors:  Simon Timbrell; Sarah Al-Himdani; Oliver Shaw; Kian Tan; Julie Morris; Nigel Bundred
Journal:  Ann Surg Oncol       Date:  2016-11-11       Impact factor: 5.344

Review 4.  Different types of implants for reconstructive breast surgery.

Authors:  Nicola Rocco; Corrado Rispoli; Lorenzo Moja; Bruno Amato; Loredana Iannone; Serena Testa; Andrea Spano; Giuseppe Catanuto; Antonello Accurso; Maurizio B Nava
Journal:  Cochrane Database Syst Rev       Date:  2016-05-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.